We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Will Not Change Ace-Inhibitor Warnings, Despite New Data
FDA Will Not Change Ace-Inhibitor Warnings, Despite New Data
June 7, 2006
The FDA will not change its warnings for pregnant women taking certain anti-hypertension medicines — even though a study it cosponsored shows an elevated risk of birth defects in the first trimester.